Market Research

Psychedelic Invest is your source for the latest business and investing news about the burgeoning psychedelics industry.

Want To Work in Psychedelics? The Industry Needs More Trial Screeners.

Aug 14 • 15 min read

Psychedelic clinical studies have become a cornerstone in the evolving landscape of mental health treatment. With conditions like depression, PTSD, and anxiety reaching alarming prevalence, the medical community is increasingly turning to innovative approaches, including the controlled use of psychedelics. Substances like psilocybin, MDMA, and LSD, once associated with the counterculture movement of the 1960s,…

Denial of Lykos’ MDMA-Assisted PTSD Therapy Followed by Retraction of Related Studies

Aug 12 • 3 min read

A day after the regulatory rejection of Lykos Therapeutics’ MDMA-assisted therapy for PTSD, the scientific community faced another setback as a prominent medical journal retracted three significant studies on the same subject. On Saturday, the journal Psychopharmacology formally pulled three papers that investigated the use of MDMA, a psychoactive drug, for treating post-traumatic stress disorder…

FDA Denies Lykos and Requests Another Trial

Aug 9 • 3 min read

The FDA issued a complete response letter regarding Lykos’ drug application for its midomafetamine capsules, an MDMA-based treatment designed for adults with PTSD. The agency, in a statement released on Friday afternoon, requested an additional Phase 3 trial to better assess the drug’s safety and efficacy. Amy Emerson, CEO of Lykos, expressed her deep disappointment…

Oregon Grants First Psychedelic Edibles Manufacturer License

Aug 7 • 4 min read

Oregon has made history by awarding its first-ever psychedelic edibles manufacturer license to Spiritus Oregon, a company based in Milwaukie known for producing psilocybin edibles. This significant milestone marks a new era in the state’s approach to psilocybin, opening doors for innovative therapies and products aimed at enhancing well-being. Spiritus Oregon’s Breakthrough in Psychedelic Edibles…

The Potential of Psilocybin for Alcohol Addiction Treatment

Aug 1 • 4 min read

Alcohol use disorder (AUD) is a debilitating condition marked by an inability to regulate or stop drinking, despite experiencing severe health, social, and occupational consequences. Traditional treatments encompass medication, behavioral therapy, and support groups. Nevertheless, many individuals struggle to achieve long-term recovery, underscoring the necessity for more effective therapeutic options. Psilocybin’s Impact on Alcohol Consumption…

Pages: 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253